Molecular markers of treatment irregularity of statins: influence of polymorphisms in <i>SLCO1B1</i> and <i>SLCO1B3</i>
Our findings suggest an association between specific SLCO gene variants and irregularities in statin treatment.
Authors
- Luiz Carlos Van der Sand
- Silvana Almeida (ORCID: https://orcid.org/0000-0001-7959-3723)
- Lisiane Smiderle (ORCID: https://orcid.org/0000-0003-2797-2427)
- Renan Canibal Pires (ORCID: https://orcid.org/0009-0008-7856-3301)
- Mara Helena Hutz (ORCID: https://orcid.org/0000-0002-9146-1229)
- Maria Elvira Wagner Ferreira
- Cézar Roberto Van Der Sand (ORCID: https://orcid.org/0000-0002-9559-394X)
- Marilu Fiegenbaum (ORCID: https://orcid.org/0000-0002-5408-2078)
- Jéssica Louise Benelli (ORCID: https://orcid.org/0000-0002-9309-5349)
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- Fundação Universitária de Cardiologia (BR)
- Angiologica (Italy) (IT)
- University of Health Sciences (SO)
- University of Health Sciences Antigua (AG)
- University of Rio Grande and Rio Grande Community College (US)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2025-08-13
- DOI
- https://doi.org/10.1080/14622416.2025.2562797
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00